Steven Cohen’s Allergan plc AGN Stock Holding History

Steven Cohen’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,500	Closed	-$2.61M	–	1372
2019 Q3	$2.61M	Buy	+15,500	New	+$2.53M	0.02%	558

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Steven Cohen's AGN Position: Q3 2019 in Review

Steven Cohen sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 25,000 shares — an estimated $4.07M sold.

Steven Cohen first reported a position in AGN in Q2 2014 and held it in 13 quarters. The position peaked at $92.2M in Q3 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Steven Cohen reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Steven Cohen sold 25,000 Allergan plc shares in Q3 2019, an estimated $4.07M.
Steven Cohen first reported a position in Allergan plc in Q2 2014 and held it in 13 quarters.
Steven Cohen's Allergan plc position peaked at $92.2M in Q3 2017.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.